Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$2.71 - $19.57 $16,991 - $122,703
-6,270 Reduced 43.0%
8,310 $23,000
Q3 2023

Nov 08, 2023

BUY
$18.08 - $23.45 $2,892 - $3,752
160 Added 1.11%
14,580 $266,000
Q2 2023

Aug 11, 2023

BUY
$20.98 - $31.42 $128,187 - $191,976
6,110 Added 73.53%
14,420 $311,000
Q4 2022

Feb 07, 2023

BUY
$29.75 - $39.26 $247,222 - $326,250
8,310 New
8,310 $307,000

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $237M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.